Benefix 3000 Unit (Coagulation Factor Ix (Recombinant) POWDER FOR SOLUTION) 3000 UNIT

Benefix 3000 Unit is a recombinant coagulation factor IX used to manage bleeding episodes in hemophilia B patients. This intravenous powder for solution supports clotting and is manufactured by Pfizer Canada ULC.

Strength

3000 UNIT

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Benefix 3000 Unit is primarily used to control bleeding episodes in individuals with hemophilia B, a condition characterized by a deficiency in coagulation factor IX. It is designed to help the blood clot properly, reducing the risk of prolonged bleeding. This medication is often administered intravenously to provide rapid support during bleeding events.

Side Effects

Common effects of Benefix 3000 Unit may include localized reactions at the injection site, such as redness or swelling. Some users might experience mild to moderate headaches or nausea. These effects are generally temporary and should be discussed with a healthcare provider if they persist or worsen.

Precautions & Warnings

Benefix 3000 Unit should be handled with care, ensuring proper storage and preparation to maintain its effectiveness. It is important to follow the prescribed guidelines for administration and to monitor for any signs of allergic reactions. Users should inform their healthcare provider about any pre-existing conditions or medications they are taking.

Avoid Interactions

Benefix 3000 Unit may interact with other medications, particularly those that affect blood clotting. It is advisable to consult a healthcare provider before using this medication alongside other treatments. Alcohol and certain supplements might also influence its effectiveness, so it is best to discuss all potential interactions with a medical professional.

Frequently Asked Questions

Benefix 3000 Unit is used to manage bleeding episodes in individuals with hemophilia B by supporting proper blood clotting.

Benefix 3000 Unit is administered intravenously as a powder that is reconstituted into a solution.

Common side effects may include localized reactions at the injection site, headaches, and nausea.

It is important to consult a healthcare provider before using Benefix 3000 Unit with other medications to avoid potential interactions.

Benefix 3000 Unit is manufactured by Pfizer Canada ULC.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.